Pablo Tamayo
#126,029
Most Influential Person Now
Researcher ORCID ID = 0000-0002-9360-4668
Pablo Tamayo's AcademicInfluence.com Rankings
Pablo Tamayocomputer-science Degrees
Computer Science
#5289
World Rank
#5587
Historical Rank
Algorithms
#181
World Rank
#184
Historical Rank
Machine Learning
#1344
World Rank
#1365
Historical Rank
Database
#2446
World Rank
#2563
Historical Rank

Pablo Tamayobiology Degrees
Biology
#7965
World Rank
#10969
Historical Rank
Bioinformatics
#88
World Rank
#90
Historical Rank
Computational Biology
#149
World Rank
#149
Historical Rank

Download Badge
Computer Science Biology
Pablo Tamayo's Degrees
- PhD Bioinformatics University of California, San Diego
- Masters Computer Science Stanford University
- Bachelors Computer Science Stanford University
Similar Degrees You Can Earn
Why Is Pablo Tamayo Influential?
(Suggest an Edit or Addition)Pablo Tamayo's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles (2005) (33800)
- Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. (1999) (12024)
- PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes (2003) (6859)
- Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. (2010) (5816)
- The Molecular Signatures Database Hallmark Gene Set Collection (2015) (4513)
- Molecular signatures database (MSigDB) 3.0 (2011) (3692)
- Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. (1999) (3275)
- The Molecular Signatures Database (MSigDB) hallmark gene set collection. (2015) (2763)
- Gene expression correlates of clinical prostate cancer behavior. (2002) (2549)
- Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning (2002) (2443)
- Prediction of central nervous system embryonal tumour outcome based on gene expression (2002) (2421)
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 (2009) (2300)
- Multiclass cancer diagnosis using tumor gene expression signatures (2001) (2107)
- GenePattern 2.0 (2006) (1785)
- Consensus Clustering: A Resampling-Based Method for Class Discovery and Visualization of Gene Expression Microarray Data (2003) (1757)
- Metagenes and molecular pattern discovery using matrix factorization (2004) (1750)
- GSEA-P: a desktop application for Gene Set Enrichment Analysis (2007) (1121)
- Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. (2003) (952)
- Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway (2017) (911)
- SOX2 Is an Amplified Lineage Survival Oncogene in Lung and Esophageal Squamous Cell Carcinomas (2009) (904)
- Identification of RPS14 as a 5q- syndrome gene by RNA interference screen (2007) (902)
- Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. (2000) (855)
- MEDULLOBLASTOMA EXOME SEQUENCING UNCOVERS SUBTYPE-SPECIFIC SOMATIC MUTATIONS (2012) (686)
- Chemosensitivity prediction by transcriptional profiling (2001) (663)
- Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. (2011) (643)
- Discovering functional relationships between RNA expression and chemotherapeutic susceptibility using relevance networks. (2000) (639)
- CDK8 is a colorectal cancer oncogene that regulates β-catenin activity (2008) (630)
- Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer Cells (2009) (546)
- Prognostically relevant gene signatures of high-grade serous ovarian carcinoma. (2012) (509)
- Automated high-dimensional flow cytometric data analysis (2009) (434)
- Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer (2011) (412)
- A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors. (2014) (412)
- Subclass Mapping: Identifying Common Subtypes in Independent Disease Data Sets (2007) (369)
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA , IDH 1 , EGFR , and NF 1 Citation Verhaak (2010) (362)
- Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies (2014) (320)
- Molecular classification of multiple tumor types (2001) (291)
- Estimating Dataset Size Requirements for Classifying DNA Microarray Data (2003) (272)
- Class prediction and discovery using gene expression data (2000) (248)
- Distinct physiological states of Plasmodium falciparum in malaria-infected patients (2007) (246)
- Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway (2010) (217)
- Support vector ma-chine classification of microarray data (2000) (211)
- Microarray data mining: facing the challenges (2003) (206)
- Compendium of Immune Signatures Identifies Conserved and Species-Specific Biology in Response to Inflammation. (2016) (202)
- Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation. (2005) (199)
- High expression of lymphocyte-associated genes in node-negative HER2+ breast cancers correlates with lower recurrence rates. (2007) (196)
- Systematic Evaluation of Molecular Networks for Discovery of Disease Genes. (2018) (184)
- Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses (2018) (180)
- MYC regulation of a “poor-prognosis” metastatic cancer cell state (2010) (173)
- High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines (2016) (172)
- Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Oncogene ID4 (2012) (171)
- An Erythroid Differentiation Signature Predicts Response to Lenalidomide in Myelodysplastic Syndrome (2008) (170)
- Inhibition of KRAS-driven tumorigenicity by interruption of an autocrine cytokine circuit. (2014) (167)
- Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies (2014) (161)
- High-throughput Phenotyping of Lung Cancer Somatic Mutations. (2016) (157)
- Metagene projection for cross-platform, cross-species characterization of global transcriptional states (2007) (152)
- A functional landscape of resistance to ALK inhibition in lung cancer. (2015) (151)
- SQSTM1 is a pathogenic target of 5q copy number gains in kidney cancer. (2013) (137)
- A Platform of Synthetic Lethal Gene Interaction Networks Reveals that the GNAQ Uveal Melanoma Oncogene Controls the Hippo Pathway through FAK. (2019) (133)
- Targeting an IKBKE cytokine network impairs triple-negative breast cancer growth. (2014) (125)
- A resampling-based method for class discovery and visualization of gene expression microarray data (2003) (125)
- A genetic basis for the variation in the vulnerability of cancer to DNA damage (2016) (124)
- Systematic Functional Interrogation of Rare Cancer Variants Identifies Oncogenic Alleles. (2016) (124)
- ATARiS: Computational quantification of gene suppression phenotypes from multisample RNAi screens (2013) (124)
- Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma Subgroups. (2018) (113)
- Metabolic Rewiring by Oncogenic BRAF V600E Links Ketogenesis Pathway to BRAF-MEK1 Signaling. (2015) (112)
- Integrative radiogenomic profiling of squamous cell lung cancer. (2013) (106)
- Illuminating the Onco-GPCRome: Novel G protein–coupled receptor-driven oncocrine networks and targets for cancer immunotherapy (2019) (102)
- Twist1 Suppresses Senescence Programs and Thereby Accelerates and Maintains Mutant Kras-Induced Lung Tumorigenesis (2012) (100)
- Assembly and activation of the Hippo signalome by FAT1 tumor suppressor (2018) (99)
- GeneCluster 2.0: an advanced toolset for bioarray analysis (2004) (99)
- A Curated Resource for Phosphosite-specific Signature Analysis* (2018) (93)
- Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function ERF Mutations. (2017) (91)
- An expanded universe of cancer targets (2021) (86)
- Characterizing genomic alterations in cancer by complementary functional associations (2016) (86)
- Combining gene expression profiles and clinical parameters for risk stratification in medulloblastomas. (2004) (84)
- Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells. (2008) (81)
- CDK 8 is a colorectal cancer oncogene that regulates b-catenin activity (2008) (77)
- Predicting relapse in patients with medulloblastoma by integrating evidence from clinical and genomic features. (2011) (74)
- Integrated Genomic Analysis of the 8q24 Amplification in Endometrial Cancers Identifies ATAD2 as Essential to MYC-Dependent Cancers (2013) (74)
- Systematic interrogation of 3q26 identifies TLOC1 and SKIL as cancer drivers. (2013) (73)
- An Analytical Method for Multiclass Molecular Cancer Classification (2003) (72)
- The limitations of simple gene set enrichment analysis assuming gene independence (2011) (66)
- An RNA Profile Identifies Two Subsets of Multiple Sclerosis Patients Differing in Disease Activity (2012) (60)
- Role of Tet1/3 Genes and Chromatin Remodeling Genes in Cerebellar Circuit Formation (2016) (59)
- Gene signatures related to B‐cell proliferation predict influenza vaccine‐induced antibody response (2014) (57)
- Visualizing and interpreting single-cell gene expression datasets with Similarity Weighted Nonnegative Embedding (2018) (52)
- Joint Modeling and Registration of Cell Populations in Cohorts of High-Dimensional Flow Cytometric Data (2013) (49)
- DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with In Silico Analysis to Identify Novel Therapeutic Targets (2016) (48)
- Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers. (2016) (46)
- Portraits of breast cancer progression (2007) (46)
- Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers (2019) (45)
- Genome-scale analysis identifies paralog lethality as a vulnerability of chromosome 1p loss in cancer (2018) (45)
- APOBEC-related mutagenesis and neo-peptide hydrophobicity: implications for response to immunotherapy (2018) (44)
- OTX2 Activity at Distal Regulatory Elements Shapes the Chromatin Landscape of Group 3 Medulloblastoma. (2017) (43)
- Overcoming Resistance to Dual Innate Immune and MEK Inhibition Downstream of KRAS. (2018) (42)
- MicroSCALE Screening Reveals Genetic Modifiers of Therapeutic Response in Melanoma (2012) (42)
- The GenePattern Notebook Environment. (2017) (35)
- STRIPAK directs PP2A activity toward MAP4K4 to promote oncogenic transformation of human cells (2020) (35)
- HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers (2020) (35)
- Cascades of transcriptional induction during human lymphocyte activation. (2001) (34)
- Decomposing Oncogenic Transcriptional Signatures to Generate Maps of Divergent Cellular States. (2017) (33)
- GeneCruiser: a web service for the annotation of microarray data (2005) (33)
- Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials (2018) (31)
- A Curated Resource for Phosphosite-specific Signature Analysis. (2019) (31)
- KRAS Genomic Status Predicts the Sensitivity of Ovarian Cancer Cells to Decitabine. (2015) (30)
- DNA methylation identifies genetically and prognostically distinct subtypes of myelodysplastic syndromes. (2019) (27)
- Metformin inhibits progression of Head and Neck Squamous Cell Carcinoma by acting Directly on Carcinoma Initiating Cells. (2019) (26)
- Role of ultraviolet mutational signature versus tumor mutation burden in predicting response to immunotherapy (2020) (26)
- Epigenetic inactivation of the tumor suppressor BIN1 drives proliferation of SNF5-deficient tumors (2012) (25)
- Kataegis Expression Signature in Breast Cancer Is Associated with Late Onset, Better Prognosis, and Higher HER2 Levels. (2016) (25)
- Identification of novel prostate cancer drivers using RegNetDriver: a framework for integration of genetic and epigenetic alterations with tissue-specific regulatory network (2017) (25)
- A strategy for oligonucleotide microarray probe reduction (2002) (24)
- Cannabinoids Promote Progression of HPV-Positive Head and Neck Squamous Cell Carcinoma via p38 MAPK Activation (2020) (24)
- Functional Precision Medicine Identifies New Therapeutic Candidates for Medulloblastoma (2020) (21)
- Integrative functional genomics identifies RINT1 as a novel GBM oncogene (2012) (18)
- Prediction of response to therapy with ezatiostat in lower risk myelodysplastic syndrome (2012) (17)
- Mesenchymal and MAPK Expression Signatures Associate with Telomerase Promoter Mutations in Multiple Cancers (2020) (16)
- Macrophage Syk–PI3Kγ Inhibits Antitumor Immunity: SRX3207, a Novel Dual Syk–PI3K Inhibitory Chemotype Relieves Tumor Immunosuppression (2020) (15)
- Abstract S1-01: Whole exome and transcriptome sequencing of resistant ER+ metastatic breast cancer (2017) (13)
- TEAD1 and TEAD3 play redundant roles in the regulation of human epidermal proliferation. (2020) (13)
- High-throughput Phenotyping of Lung Cancer Somatic Mutations. (2016) (13)
- Cancer Genomics and Molecular Pattern Recognition (2002) (13)
- Tissue- and development-stage–specific mRNA and heterogeneous CNV signatures of human ribosomal proteins in normal and cancer samples (2020) (13)
- SPT6 promotes epidermal differentiation and blockade of an intestinal-like phenotype through control of transcriptional elongation (2021) (11)
- Genomic and Proteomic Alterations in Desmoplastic Small Round Blue-Cell Tumors. (2018) (10)
- A Genome-Wide siRNA Screen in Mammalian Cells for Regulators of S6 Phosphorylation (2015) (10)
- BTK Inhibition Reverses MDSC-Mediated Immunosuppression and Enhances Response to Anti-PDL1 Therapy in Neuroblastoma (2021) (9)
- Breast cancer stratification from analysis of micro-array data of micro-dissected specimens. (2007) (8)
- Gene Set Enrichment Analysis Made Right (2011) (8)
- Characterization of Citrus tristeza virus isolates from Colombia (2013) (7)
- Human induced pluripotent stem cell‐derived macrophages ameliorate liver fibrosis (2021) (7)
- Modelling bistable tumour population dynamics to design effective treatment strategies. (2019) (7)
- Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Target ID4 (2012) (6)
- Modelling bistable tumour population dynamics to design effective treatment strategies (2018) (6)
- Ovarian Cancer Oncogene Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the (2012) (6)
- WNT Signaling Driven by R-spondin 1 and LGR6 in High-grade Serous Ovarian Cancer (2020) (5)
- TORC1/2 kinase inhibition depletes glutathione and synergizes with carboplatin to suppress the growth of MYC-driven medulloblastoma. (2021) (5)
- The multikinase inhibitor RXDX-105 is effective against neuroblastoma in vitro and in vivo (2019) (5)
- Publisher Correction: Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers (2019) (5)
- Darwin : A Scalable Integrated System for Data Mining (1999) (5)
- Microarray Data Analysis: Cancer Genomics and Molecular Pattern Recognition (2003) (5)
- Constellation Map: Downstream visualization and interpretation of gene set enrichment results (2015) (4)
- application to hematopoietic differentiation Interpreting patterns of gene expression with self-organizing maps: Methods and (2007) (4)
- CHMP2A regulates tumor sensitivity to natural killer cell-mediated cytotoxicity (2022) (4)
- Responses to immunotherapy in hepatocellular carcinoma patients with nonalcoholic steatohepatitis cirrhosis. (2022) (3)
- Golub , Monitoring and Class Prediction by Gene Expression Molecular Classification of Cancer : Class Discovery (2007) (3)
- KITlow Cells Mediate Imatinib Resistance in Gastrointestinal Stromal Tumor (2021) (3)
- Analysis of CDK12 alterations in a pan‐cancer database (2021) (3)
- A method for downstream analysis of gene set enrichment results facilitates the biological interpretation of vaccine efficacy studies (2016) (3)
- Su.86. Automated High-dimensional Flow Cytometric Data Analysis (2008) (2)
- Abstract 4868: Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations within a wide spectrum of genetic heterogeneity (2012) (2)
- Better Definition for Brainstem Tumors: Advances in Diffusion Tensor Imaging (2010) (2)
- Cyclin E Overexpression in Human Mammary Epithelial Cells Promotes Epithelial Cancer-Specific Copy Number Alterations (2019) (2)
- The Prognostic Significance of Homologous Recombination Repair Pathway Alterations in Metastatic Hormone Sensitive Prostate Cancer. (2021) (2)
- GNAS‐PKA Oncosignaling Network in Colorectal Cancer (2018) (2)
- An Erythroid Differentiation Gene Expression Signature Predicts Response to Lenalidomide in Myelodysplasia. (2006) (1)
- Abstract 968: Targeting FAK inhibits YAP-dependent tumor growth in uveal melanoma (2018) (1)
- Abstract 1310: Systematic evaluation of gene networks for discovery of disease genes (2018) (1)
- STRIPAK directs PP2A activity toward MAP4K4 to promote oncogenic transformation (2019) (1)
- Abstract 1313: Mutually exclusive somatic mutations in WNT pathway medulloblastomas reveal a critical interaction between DDX3X and SMARCA4 (2012) (1)
- Abstract 66: Epigenetic inactivation of the tumor suppressor BIN1 drives proliferation of SNF5-deficient tumors (2011) (1)
- CRRAO Advanced Institute of Mathematics, Statistics and Computer Science (AIMSCS) (2013) (1)
- Inferring cellular and molecular processes in single-cell data with non-negative matrix factorization using Python, R, and GenePattern Notebook implementations of CoGAPS (2022) (1)
- Microarray Data Analysis (2003) (1)
- Visualizing single-cell RNA-seq datasets with Similarity Weighted Nonnegative Embedding (SWNE) (2018) (1)
- Therapeutics , Targets , and Chemical Biology Integrative Radiogenomic Pro fi ling of Squamous Cell Lung Cancer (2013) (1)
- Identifying novel molecular vulnerabilities to PTK2/FAK inhibition in G α q‐driven uveal melanoma using a kinome‐wide CRISPR/Cas9 screen (2019) (1)
- Genome-scale analysis identifies paralog lethality as a vulnerability of chromosome 1p loss in cancer (2018) (1)
- Integrative Radiogenomic Profiling Identifies BRAF Mutations as Novel Radiotherapeutic Targets in Adenocarcinomas of the Lung (2014) (1)
- Abstract PR04: A melanoma transcriptional state distinction influences sensitivity to MAPK pathway inhibitors (2015) (1)
- Gene Expression Studies May Identify Lower Risk Myelodysplastic Syndrome Patients Likely to Respond to Therapy with Ezatiostat Hydrochloride (TLK199) (2011) (1)
- Abstract 1684: Multi-omics profiling of breast cancers during neoadjuvant chemotherapy identified distinct molecular changes and biomarkers associated with clinical response (2019) (0)
- Abstract 3035: Decomposing oncogenic transcriptional signatures to generate maps of divergent cellular states (2017) (0)
- Abstract 4760: Molecular classification and risk-stratification in medulloblastoma using an integrative genomic approach (2011) (0)
- PD52-12 ANALYSIS OF THE PROGNOSTIC SIGNIFICANCE OF CIRCULATING TUMOR DNA (CTDNA) IN METASTATIC CASTRATE RESISTANT PROSTATE CANCER (MCRPC) (2020) (0)
- Immunotherapy treatment responses in hepatocellular carcinoma patients with nonalcoholic fatty liver disease cirrhosis. (2022) (0)
- MB-27PATHWAY ANALYSIS OF A HUMAN NEURAL STEM CELL MODEL OF AGGRESSIVE MEDULLOBLASTOMA REVEALS CKD INBHIBITION AS A POTENTIAL THERAPEUTIC MODALITY (2015) (0)
- Abstract PR12: High-throughput gene expression profiling as a generalizable assay for determination of mutation impact on gene function (2015) (0)
- GenePattern Notebooks: An integrative analytical environment for genomic research (2016) (0)
- 46. Data driven refinement of gene signatures for enrichment analysis and cell state characterization (2022) (0)
- Comprehensive Genomic Profiling Reveals Complex and Distinct but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials (2018) (0)
- Systematic Evaluation of M olecular Networks for Discovery of Disease Genes Graphical (2018) (0)
- On the Parallelization of CHARMM on the CM-5/5E (1996) (0)
- Assembly and activation of the Hippo signalome by FAT1 tumor suppressor (2018) (0)
- Characterization of advanced hepatocellular carcinoma patients via a multi-omic cancer registry. (2020) (0)
- Abstract A09: Decomposing Oncogenic Transcriptional Signatures to Generate Maps of RAS/MAPK Cellular States (2017) (0)
- Gαs (GNAS) suppression of the p53 genomic‐stability checkpoint unleashes RAS‐driven oncogenesis (2020) (0)
- Abstract 4259: The radiogenomic landscape of cancer (2014) (0)
- Abstract 3315: Functional genomic profiling of lung adenocarcinoma identifies BRAF mutations as novel therapeutic targets (2015) (0)
- DNA Methylation Identifies Genetically and Prognostically Distinct Subtypes of MDS (2018) (0)
- Title: KRAS genomic status predicts the sensitivity of ovarian cancer cells to decitabine Running Title: KRAS status predicts sensitivity to decitabine in ovarian cancer Authors: Stewart ML, Tamayo (2015) (0)
- MBRS-65. CHEMI-GENOMIC ANALYSIS OF PATIENT-DERIVED XENOGRAFTS TO IDENTIFY PERSONALIZED THERAPIES FOR MEDULLOBLASTOMA (2016) (0)
- Abstract 3207: GenePattern Notebook: An integrative analytical environment for cancer research (2020) (0)
- A Genetic Basis for Variation in the Vulnerability of Cancer to Ionizing Radiation (2016) (0)
- Abstract B21: Childhood Cancer Molecular Map (C2M2) to define medulloblastoma heterogeneity and predict treatment response (2020) (0)
- Abstract 2476: DiSCoVERing innovative therapies for rare tumors: Combining genetically accurate disease models with advanced in silico analysis to identify novel therapeutic targets (2016) (0)
- Abstract #5608: Synthetic lethal interaction between oncogenic KRAS dependency and suppression of STK33 in human cancer cells (2009) (0)
- Abstract 1903: GenePattern Notebook: An integrative analytical environment for cancer research (2016) (0)
- MB-103DiSCoVERing INNOVATIVE THERAPIES: COMBINING GENETICALLY ACCURATE DISEASE MODELS OF MEDULLOBLASTOMA WITH ADVANCED IN SILICO ANALYSIS TO IDENTIFY NOVEL THERAPEUTIC TARGETS (2016) (0)
- Abstract P5-06-02: A gene expression meta-analysis identifies microenvironment differences in cellular composition and cell-cell interactions associated with breast cancer invasion (2022) (0)
- Abstract A23: An integrated platform for the functional annotation of the cancer genome (2009) (0)
- Abstract 5865: The composition of the human ribosome varies significantly in different normal and malignant tissues (2020) (0)
- Identification of novel prostate cancer drivers using RegNetDriver: a framework for integration of genetic and epigenetic alterations with tissue-specific regulatory network (2017) (0)
- Differential Analysis of Stromal-Epithelial Interactions between In Situ and Invasive Breast Cancer using Gene Expression Profiling (2022) (0)
- MBRS-30. TORC1/2 INHIBITION SENSITIZES MYC-DRIVEN MEDULLOBLASTOMA CELLS TO CARBOPLATIN CHEMOTHERAPY (2018) (0)
- Metagene projection strategies for discovering mechanisms of T cell differentiation in gene expression profiling data (58.13) (2012) (0)
- Systematic Investigation of Genetic Vulnerabilities Across Cancer Cell Lines Reveals Lineage Specific Radiotherapeutic Determinants (2015) (0)
- Integrative Radiotranscriptomic Analysis of Breast Carcinoma Identifies Androgen Receptor as a Target for Therapeutic Sensitization (2015) (0)
- NF-κB Activation in Breast Cancer Occurs Via Different Mechanisms in Triple Negative and HER2+ Tumors with Lymphocytic Infiltrate. (2009) (0)
- Author response: STRIPAK directs PP2A activity toward MAP4K4 to promote oncogenic transformation of human cells (2020) (0)
- Data Preprocessing Data normalization , Imputation Gene Filtering PCA 85 % variation k-Level Ensemble Consensus Clustering (2007) (0)
- A Functional Landscape o f Resistance to ALK Inhibition in Lung Cancer Graphical Abstract Highlights (2015) (0)
- Abstract 1416: Pan-cancer mutual vulnerability and viability (2018) (0)
- Abstract PR5: Treatment of ovarian cancer with targeted tumor-penetrating siRNA nanocomplexes (2012) (0)
- Systematic loss of function screens identify pathway specific functional circular RNAs (2022) (0)
- A strategy for oligonucleotide microarray probe reduction Citation (2002) (0)
- A Combined Genetic Programming for Microarray Data Analysis (2020) (0)
- MOTIVATING UNDERGRADUATE STUDENTS THE STUDY OF CHEMISTRY THROUGH A PRACTICAL PROBLEM SOLUTION (2014) (0)
- Abstract 5032: Data driven refinement of gene signatures for enrichment analysis and cell state characterization (2022) (0)
- GNAS‐PKA Oncosignaling Network in Colorectal Cancer (2017) (0)
- NRF2 Is a Novel Oncogene and Biomarker of Therapeutic Resistance in Non-Small Cell Lung Cancer : Novel Therapies/Experimental Therapies (2014) (0)
- Abstract PR04: High-throughput gene expression profiling as a generalizable assay for determination of mutation impact on gene function (2015) (0)
- NRF2 Is a Novel Oncogene and Biomarker of Therapeutic Resistance in Non-Small Cell Lung Cancer (2014) (0)
- MOLECULAR CANCER THERAPEUTICS | TARGETING DRUG RESISTANCE KIT Cells Mediate Imatinib Resistance in Gastrointestinal Stromal Tumor (2021) (0)
- Novel Computational Methods to Enhance the Analysis of Cytometric Immunophenotypes (2007) (0)
- Diagnostic de tumeur cerebrale et prediction de resultat de traitement (2002) (0)
- Discovery of novel candidate oncogenic pathway activators with REVEALER (2011) (0)
- Abstract 1555: Pan-cancer patterns of synthetic lethality: statistical modeling of gene dependency profiles (2017) (0)
- Analysis of the prognostic significance of circulating tumor DNA (ctDNA) in metastatic castrate-resistant prostate cancer (mCRPC). (2020) (0)
- NF-κB activation in basal and HER2+ breast cancers occurs via different mechanisms (2008) (0)
- Abstract 263: KITlowcells mediate Imatinib resistance and disease persistence in gastrointestinal stromal tumor (2019) (0)
- The Radiogenomic Landscape of Cancer (2014) (0)
- Abstract A20: Gαq controls the Hippo pathway through MOB1 tyrosine phosphorylation by FAK (2020) (0)
- Comprehensive Genomic Profiling Identifies BRAF Mutations as Novel Radiotherapeutic Targets in Lung Adenocarcinoma (2015) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Pablo Tamayo?
Pablo Tamayo is affiliated with the following schools: